Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 197

1.

Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.

Wang EA, Stein JP, Bellavia RJ, Broadwell SR.

Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30. Review.

PMID:
28758319
2.

Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.

Wang EA, Broadwell SR, Bellavia RJ, Stein JP.

J Gastrointest Oncol. 2017 Apr;8(2):266-278. doi: 10.21037/jgo.2016.11.08. Review.

3.

Venturing into the uncanny valley of mind-The influence of mind attribution on the acceptance of human-like characters in a virtual reality setting.

Stein JP, Ohler P.

Cognition. 2017 Mar;160:43-50. doi: 10.1016/j.cognition.2016.12.010. Epub 2016 Dec 30.

PMID:
28043026
4.

Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.

Mata DA, Groshen S, Von Rundstedt FC, Skinner DG, Stadler WM, Cote RJ, Stein JP, Lerner SP.

J Surg Oncol. 2015 Jun;111(7):923-8. doi: 10.1002/jso.23903. Epub 2015 Apr 14.

5.

Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.

von Rundstedt FC, Mata DA, Groshen S, Stein JP, Skinner DG, Stadler WM, Cote RJ, Kryvenko ON, Godoy G, Lerner SP.

BJU Int. 2015 Jul;116(1):44-9. doi: 10.1111/bju.12997. Epub 2015 Mar 25.

6.

Social determinants of health predict state incidence of HIV and AIDS: a short report.

Zeglin RJ, Stein JP.

AIDS Care. 2015;27(2):255-9. doi: 10.1080/09540121.2014.954983. Epub 2014 Sep 16.

PMID:
25225050
7.

A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine.

Birkhahn M, Mitra AP, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ.

Eur J Cancer. 2013 Oct;49(15):3159-68. doi: 10.1016/j.ejca.2013.04.033. Epub 2013 Jul 9.

8.

Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ.

Cancer. 2013 Feb 15;119(4):756-65. doi: 10.1002/cncr.27763. Epub 2013 Jan 14.

9.

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

Stadler WM, Lerner SP, Groshen S, Stein JP, Shi SR, Raghavan D, Esrig D, Steinberg G, Wood D, Klotz L, Hall C, Skinner DG, Cote RJ.

J Clin Oncol. 2011 Sep 1;29(25):3443-9. doi: 10.1200/JCO.2010.34.4028. Epub 2011 Aug 1.

10.

Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy.

Birkhahn M, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG, Cote RJ.

BJU Int. 2011 Sep;108(5):660-4. doi: 10.1111/j.1464-410X.2010.09978.x. Epub 2011 Jan 12.

11.

Surgical considerations for elderly urologic oncology patients.

Schuckman AK, Stein JP, Skinner D.

Urol Oncol. 2009 Nov-Dec;27(6):628-32. doi: 10.1016/j.urolonc.2009.07.018.

PMID:
19879473
12.

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.

Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF.

J Urol. 2009 Nov;182(5):2182-7. doi: 10.1016/j.juro.2009.07.017. Epub 2009 Sep 15.

PMID:
19758623
13.

Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.

Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.

J Urol. 2009 May;181(5):2052-8; discussion 2058-9. doi: 10.1016/j.juro.2009.01.020. Epub 2009 Mar 14.

PMID:
19286213
14.

Training the urologic oncologist of the future: where are the challenges?

Buscarini M, Stein JP.

Urol Oncol. 2009 Mar-Apr;27(2):193-8. doi: 10.1016/j.urolonc.2008.07.026.

PMID:
19285233
15.

Outcomes of patients with clinical CIS-only disease treated with radical cystectomy.

Huang GJ, Kim PH, Skinner DG, Stein JP.

World J Urol. 2009 Feb;27(1):21-5. doi: 10.1007/s00345-008-0344-2. Epub 2008 Dec 9.

PMID:
19066905
16.

Outcomes of radical cystectomy.

Thalmann GN, Stein JP.

BJU Int. 2008 Nov;102(9 Pt B):1279-88. doi: 10.1111/j.1464-410X.2008.07971.x. No abstract available.

PMID:
19035893
17.

Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.

Dorff TB, Tsao-Wei D, Miranda G, Skinner DG, Stein JP, Quinn DI.

World J Urol. 2009 Feb;27(1):39-44. doi: 10.1007/s00345-008-0342-4. Epub 2008 Nov 20.

PMID:
19020886
18.

The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer.

Hadjizacharia P, Stein JP, Cai J, Miranda G.

World J Urol. 2009 Feb;27(1):33-8. doi: 10.1007/s00345-008-0345-1. Epub 2008 Nov 20.

PMID:
19020884
19.

Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients.

Reyblat P, Chan KG, Josephson DY, Stein JP, Freeman JA, Grossfeld GD, Esrig D, Ginsberg DA.

World J Urol. 2009 Feb;27(1):63-8. doi: 10.1007/s00345-008-0351-3. Epub 2008 Nov 20.

PMID:
19020878
20.

Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.

Stein JP, Hautmann RE, Penson D, Skinner DG.

Urol Oncol. 2009 Sep-Oct;27(5):466-72. doi: 10.1016/j.urolonc.2007.12.014. Epub 2008 Oct 10. Review.

PMID:
18848788

Supplemental Content

Loading ...
Support Center